Trio sues Medtronic over allegedly faulty defibrillators
A trio of patients implanted with allegedly faulty defibrillators and defibrillator leads sues Medtronic, seeking class-action status and up to $200,000 each for the estimated 25,000 patients affected by the devices.
A strongly-worded purported class action lawsuit against Medtronic (NYSE:MDT) accuses the medical device company and several of its current and former executives and board members of "criminal conspiracy, deceptive business practice and commercial bribery," according to court documents.
"Medtronic management with the timely acquiescence of the board members knowingly, intentionally, ruthlessly, recklessly, and with total indifference and disregard for human life (third degree murder in Minnesota) dumped thousands of potentially defective, extremely dangerous and perhaps fatal Medtronic defibrillators into an unsuspecting market (the stream of interstate commerce) while at the same time bribing physicians to recommend and implant the faulty cardiac devices," according to the documents.
The 3 plaintiffs – George Dalton of Alabama, Gary Patterson of Florida and Donald Alexande of Missouri – accused Medtronic and its leaders of knowingly allowing the Entrust pacemaker and Sprint Fidelis leads to hit the market.